← Leaderboards
Vikrant Sharma
Masimo Corporation
$169,854
Attributed
$509,562
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$509,562 · 1
By mechanism
U01$509,562 · 1
Top collaborators
- Surya Nauli1 shared
- Vladimir P Torchilin1 shared
Most similar at Masimo Corporation
Same institution · by research overlap
- Umberto D'alessandro$635,831
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesAnticancer ResearchAnticancer TreatmentBaseBiologicalBreast Cancer CellCancer CellCancer PatientCancer TherapyCaringCellsChemoradiationChemotherapyClinical ApplicationComparative EfficacyCoupledCytoplasmDiagnosticDoseDrug ResistanceEligibility DeterminationEndosomesEnsureAggressive Therapy